Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S J Rossi

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 21, 2007
Mycophenolate mofetil: effects on clinical transplantationC D Holt, T M Sievers, R M Ghobrial, et al.
The Annals of Thoracic Surgery|November 14, 1997
Mycophenolate mofetil for obliterative bronchiolitis syndrome after lung transplantationR I Whyte, S J Rossi, M S Mulligan, et al.
Transplantation Proceedings|March 20, 1999
Pharmacokinetic comparison of two cyclosporine A formulations, SangCya (Sang-35) and Neoral, in stable adult liver transplant recipientsR A Fisher, S H Pan, S J Rossi, et al.
Transplantation Proceedings|March 20, 1999
Pharmacokinetic and safety evaluation of SangCya vs Neoral or Sandimmune in stable renal transplant recipientsR Gaston, R R Alloway, A O Gaber, et al.
Therapeutic Drug Monitoring|December 1, 1992
Monoethylglycinexylide formation in assessing pediatric donor liver functionS J Rossi, T J Schroeder, W H Vine, et al.
Clinical Pharmacology and Therapeutics|October 23, 1997
Role of intestinal P-glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporineK S Lown, R R Mayo, A B Leichtman, et al.
Journal of Viral Hepatitis|April 14, 2006
Black patients with chronic hepatitis C have a lower sustained viral response rate than non-Blacks with genotype 1, but the same with genotypes 2/3, and this is not explained by more frequent dose reductions of interferon and ribavirin*N Bräu, E J Bini, S Currie, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 21, 2007
Mycophenolate mofetil: effects on clinical transplantationC D Holt, T M Sievers, R M Ghobrial, et al.
The Annals of Thoracic Surgery|November 14, 1997
Mycophenolate mofetil for obliterative bronchiolitis syndrome after lung transplantationR I Whyte, S J Rossi, M S Mulligan, et al.
Transplantation Proceedings|March 20, 1999
Pharmacokinetic comparison of two cyclosporine A formulations, SangCya (Sang-35) and Neoral, in stable adult liver transplant recipientsR A Fisher, S H Pan, S J Rossi, et al.
Transplantation Proceedings|March 20, 1999
Pharmacokinetic and safety evaluation of SangCya vs Neoral or Sandimmune in stable renal transplant recipientsR Gaston, R R Alloway, A O Gaber, et al.
Therapeutic Drug Monitoring|December 1, 1992
Monoethylglycinexylide formation in assessing pediatric donor liver functionS J Rossi, T J Schroeder, W H Vine, et al.
Clinical Pharmacology and Therapeutics|October 23, 1997
Role of intestinal P-glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporineK S Lown, R R Mayo, A B Leichtman, et al.
Journal of Viral Hepatitis|April 14, 2006
Black patients with chronic hepatitis C have a lower sustained viral response rate than non-Blacks with genotype 1, but the same with genotypes 2/3, and this is not explained by more frequent dose reductions of interferon and ribavirin*N Bräu, E J Bini, S Currie, et al.
Pageof 2